News
The model is trained on a massive dataset over 200 milliseconds of molecular dynamics simulations and half a million protein stability experiments ...
The new Singapore lab aims to boost AI breakthroughs, tackle societal challenges, and co-innovate in areas such as healthcare ...
Microsoft Research Asia’s Singapore facility will pursue breakthroughs in domain-specific foundation models and agentic AI for sectors like healthcare and finance, aligning with the country’s AI ...
We’re putting new models and coding agents in the hands of developers, introducing enterprise-grade agents, making our platforms like Azure AI Foundry, GitHub and Windows the best places to build, ...
Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding protein motion.
With US President Donald Trump’s tariffs causing upheaval in global trade, tech giant Microsoft is hoping to do research on ...
Singapore, its first lab in Southeast Asia dedicated to AI research. Supported by the Singapore Economic Development Board ...
The administration’s long-awaited AI Action Plan gives Silicon Valley the green light.
Microsoft launched a comprehensive strategy to position itself at the center of what it calls the “ open agentic web ” at its annual Build conference this morning, introducing dozens of AI ...
Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results